Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Alopecia areata significantly worsens quality of life in children, causing embarrassment and social issues.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Topical calcipotriol may help treat alopecia areata, especially in those with low vitamin D.

Stem cell therapy may help treat tough hair loss cases.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Combining high-dose corticosteroids with methotrexate may be effective and safe for severe alopecia areata.

Reflectance confocal microscopy confirms that yellow dots are signs of damaged hair follicles in alopecia areata.

Alopecia areata is an autoimmune disease with genetic roots, and treatments include specific topical therapies.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Ruxolitinib can help regrow hair in severe alopecia areata.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Black and Hispanic women are more likely to have alopecia areata than white women.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Diphencyprone can help some children with alopecia areata regrow hair, but it often causes side effects.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Bimatoprost helped eyelash growth in nearly half of the patients with a type of eyelash hair loss.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.